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MicroRNA-302 induces proliferation and inhibits
oxidant-induced cell death in human adipose
tissue-derived mesenchymal stem cells
JY Kim1,2,3, KK Shin1,2,3, AL Lee1,2,3, YS Kim1,2,3, HJ Park1,2,3, YK Park1,2, YC Bae4 and JS Jung*,1,2,3,5
Mesenchymal stem cells (MSCs) are a heterogeneous population of cells that proliferate in vitro as plastic-adherent cells, have a
fibroblast-like morphology, form colonies in vitro and can differentiate into bone, cartilage and fat cells. The abundance, ease
and repeatable access to subcutaneous adipose tissue and the simple isolation procedures provide clear advantages for the use
of human adipose tissue-derived mesenchymal stem cells (hASDCs) in clinical applications. We screened microRNAs (miRNAs)
that affected the proliferation and survival of hADSCs. Transfection of miR-302d mimic increased cell proliferation and protected
cells from oxidant-induced cell death in hADSCs, which was supported by flow-cytometric analysis. miR-302d did not affect the
expression of Bcl-2 family members or anti-oxidant molecules. The Nrf2-Keap1 system, which is one of the major mechanisms
for the cellular defense against oxidative stress, was not altered by transfection of miR-302d mimic. To identify the target of the
miR-302d actions on proliferation and survival of hADSCs, a microarray analysis was performed using miR-302d-overexpressing
hADSCs. Real-time PCR analysis showed that transfection of miR-302d mimic inhibited the CDKN1A and CCL5 expression.
Downregulation of CDKN1A with a specific siRNA mimicked the effect of miR-302d on hADSCs proliferation, but did not affect
miR-302d-induced cell survival. Downregulation of CCL5 protected oxidant-induced cell death as miR-302d, inhibited oxidant-
induced reactive oxygen species (ROS) generation and the addition of recombinant CCL5 inhibited the protective action of miR-
302d on oxidant-induced cell death. This study indicates that miR-302 controls proliferation and cell survival of hADSCs through
different targets and that this miRNA can be used to enhance the therapeutic efficacy of hADSCs transplantation in vivo.
Cell Death and Disease (2014) 5, e1385; doi:10.1038/cddis.2014.344; published online 21 August 2014
MicroRNAs (miRNAs) are endogenous 20- to 25-nucleotide-
long non-coding RNAs that bind to their targets through partial
sequence complementary within the 30-untranslated region
(UTR) or open reading frame (ORF) of coding mRNAs.1
These binding events result in either the degradation of the
mRNA or the inhibition of translation, thereby modulating the
expression of miRNA targets.1 miRNAs have been implicated
in many processes, including cell proliferation, apoptosis,2,3
fat metabolism,2 neuronal patterning4 and tumorigenesis.5
miR-302 is a family of eight miRNAs, which includes miR-
302a, miR-302a*, miR-302b, miR-302b*, miR-302c, miR-
302c*, miR-302d and miR-367. The first seven of these
miRNAs constitute the miR-302 family and have a highly
conserved sequence. These miRNAs are highly expressed in
embryonic stem cells (ESCs) and induced pluripotent stem
cells (iPSCs), and their expression levels rapidly decline as
pluripotent stem cells begin to differentiate.6 These observa-
tions suggest that the miR-302 family of miRNAs may have a
role in the maintenance of pluripotency or self-renewal.
Recent studies have shown that the ESC-specific cell cycle-
regulating (ESCC) family ofmiRNAs, which includesmiR-302,
enhances the reprogramming of mouse and human somatic
cells to iPSCs.7–9miR-302 is also expressed in various normal
cell types. Kumar et al.10 reported that miR-302 levels were
significantly decreased in quiescent and irradiated AG01522
normal human fibroblast (NHF) cells, which indicate a
regulatory role for miR-302 in fibroblasts quiescence and
proliferation. Kang et al.11 showed that miR-302 targets the
30- UTR of type II BMP receptor transcripts and leads to the
downregulation of BMP signaling in human primary pulmon-
ary artery smooth muscle cells. Recent studies have shown
that miR-302 targets epigenetic regulators (AOF1/2, MECP1-
p66, MECP2 and MBD2),7 cell-cycle regulators (Cyclin
D1/D2, CDK2, BMI-1 and PTEN),12, 13 TGF-b regulators
(Lefty1/2 and TGFBR2),8,14 BMP inhibitors (DAZAP2, SLAIN1,
and TOB2)12 and NR2F2.15 Most studies about the role of miR-
302 have been done in ESCs, but the function of miR-302 in
mesenchymal stem cells (MSCs) has not been studied.
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Adipose tissue-derived mesenchymal stem cells (ADSCs)
share many of the characteristics of their counterparts in bone
marrow, including an extensive proliferative potential and the
ability to differentiate toward adipogenic, osteogenic, chon-
drogenic and myogenic lineages.16–18 We have shown that
miRNAs control the proliferation and differentiation of
hADSCs.19,20 In this study, we therefore examined the role
of miR-302 in hADSCs proliferation and reactive oxygen
species (ROS)-induced cell death. Our results showed that
miR-302 increases the proliferation of hADSCs and inhibits
their oxidant-induced cell death, which may be mediated by
targeting CDKN1A and CCL5.
Results
miR-302s promote proliferation of humanMSCs. Figure 1a
shows that miR-302 members (302a, 302b, 302c, and 302d)
share a high sequence homology, differing only in the 30
hexanucleotides. We determined the effect of miR-302 on the
proliferation of MSCs. Direct cell counting showed that the
transfection of miR-302a, b, c and d mimics in hADSCs
(Figure 1b) and human bone marrow MSCs (hBMSCs)
(Supplementary Figure 1a) increased their proliferation rate.
The effects did not show any statistical significance among
miR-302 members. Colony-forming unit (CFU) assay showed
that the overexpression of miR-302s in hADSCs increased the
number of CFU (Figure 1c). Cell-cycle analysis by flow
cytometry demonstrated that the overexpression of miR-302
a, b, c and d increased the relative fraction of hADSCs in S
phase but decreased the relative fraction of hADSCs in G0/G1
phase without affecting G2/M phase (Figure 1d). In cell
proliferation assay and cell-cycle analysis, miR-302d
showed the most consistent effect among miR-302 members.
Therefore, we used miR-302d in the following experiment.
The transfection of mir-302d mimic did not affect osteogenic
and adipogenic differentiation of hADSCs (Supplementary
Figure 1b).
miR-302s protect hADSCs from oxidant-induced cell
death. We discovered during these experiments that miR-
302d-transfected cells survived well in response to stress
conditions such as oligonucleotide transfection. We therefore
determined the effect of miR-302s on cell survival under
oxidative stress which is induced by the treatment of ROS
inducers, cobalt chloride (CoCl2) and 3-morpholinosydnoni-
mine hydrochloride (SIN-1). Because cell density affected
oxidant-induced cell death in preliminary studies, we deter-
mined the effect of 100 and 200 mM of CoCl2 and 5 and
10mM of SIN-1 on cell viability in confluence state of
hADSCs. The treatment of CoCl2 and SIN-1 in hADSCs
increased cell death in a dose-dependent manner after 24 h
treatment. The transfection of miR-302s significantly pro-
tected cells from death that was induced by CoCl2 and SIN-1
(Figure 2a). We next determined the proportion of subG1
phase in miR-302d-transfected cells with CoCl2 and SIN-1
because apoptotic cells with fragmented DNA can be
identified by their subG1-DNA content. Flow-cytometric
analyses showed that the treatment of CoCl2 and SIN-1 for
24 h in confluence state of hADSCs increased the proportion
of subG1 phase cells, and that miR-302d transfection
decreased the subG1 population in the presence of CoCl2
and SIN-1 (Figure 2b; Supplementary Figure 2). Annexin V
staining, which is an early hallmark of apoptotic cell death,21
showed that transfection of miR-302d mimic decreased the
proportion of Annexin V(þ ), propidium iodide (PI) (þ ) cells
in the presence of 100mM CoCl2 and 5mM SIN-1 in hADSCs
(Figure 2c). We then determined the effects of miR-302d on
ROS generation by H2-DCFDA, which detect the overall
oxidative stress including hydrogen peroxide and hydroxyl
radicals. miR-302d transfection significantly decreased the
generation of ROS by 100mM CoCl2 or 5mM SIN-1 in
hADSCs (Figure 2d), indicating that the protective action of
miR-302 on oxidant-induced cell death may be related to the
inhibition of ROS generation.
Pro- and anti-apoptotic Bcl-2 members and anti-oxidant
mechanisms are not involved in the protection effect of
miR-302d. To investigate the molecular mechanisms of the
miR-302d-induced protection of cell death, we examined the
expression of several apoptosis regulatory proteins. Western
blot analysis of the anti-apoptotic proteins Bcl-2 and Bcl-XL
and pro-apoptotic proteins Bad, Bak and Bax showed that
the expression of these proteins was not altered by the
transfection of miR-302d (Supplementary Figure 3). We next
determined the expression of anti-oxidant molecules in
hADSCs. Real-time PCR analysis showed that the transfec-
tion of miR-302d did not affect the expression of a number of
anti-oxidant molecules, including superoxide dismutase
(SOD), catalase (CAT), glutathione peroxidase (GPX) and
glutathione S-transferase (GST). We also determined the
expression of anti-oxidant genes in the presence of 100 mM
CoCl2 or 5mM SIN-1. The treatment of CoCl2 or SIN-1
increased the expression of SOD1, SOD2, GPX1, GPX4,
GST omega 1, and the transfection of miR-302d inhibited
CoCl2-induced increase in SOD1 and SOD2 (Supplementary
Figure 4a). Another important anti-oxidant mechanism is
controlled by the Keap1/Nrf2 pathway.22 We assessed the
mRNA expression of Nrf2 and Keap1 by real-time PCR and
we did not observe a change in the expression of these
genes (Figure 3a). The treatment of CoCl2 increased
hemoxygenase-1 (HO-1) expression, one of the major anti-
oxidant enzyme and its expression is regulated by Nrf2,23 but
the quantitation of western blot experiments showed that the
transfection of miR-302d did not affect HO-1, Nrf2, phospho
Nrf2 or Keap1 levels in the absence or presence of 100mM
CoCl2 (Figure 3b). The downregulation of Nrf2 expression by
the specific siRNA (Figure 3c) also did not affect miR-302d-
induced protection of CoCl2-induced cell death (Figure 3d).
Downregulation of CDKN1A by miR-302d promotes the
proliferation of hADSCs, but does not protect oxidant-
induced cell death. To determine the targets of miR-302d
in hADSCs, we searched for candidate gene targets using
the miRWalk database, which allows for the search for
interaction information from eight established miRNA target
prediction programs (RNA22, miRanda, miRDB, TargetScan,
RNAhybrid, PITA, PICTAR and Diana-microT). We also
examined miR-302d-induced changes in gene expression of
hADSCs by microarray analysis. We found 23 genes, which
regulate cell cycle or oxidative stress, among 300 genes of
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Figure 1 miR-302 regulates cell proliferation and cell-cycle progression. (a) Sequence alignment of human miR-302 family miRNAs. (b) Effect of miR-302 on proliferation of
hADSCs. hADSCs were transfected with miR-control or miR-302, and proliferation was then assessed. Cells were counted at different time points. (c) CFU assay of transfected
hADSCs was performed by plating 60 cells on a 60-mm culture dish. The colonies were counted at 7 days after plating. *Po0.05, **Po0.01 versus miR-control. (d) Cell-cycle
analysis of miR-control- andmiR-302-transfected hADSCs. Forty-eight hours post transfection, cells were analyzed by the FACS to determine the cell-cycle distribution. 10 000 cells
were analyzed for each sample. The values represent the percentage of cells in each phase of the cell cycle. Data are shown as the mean±S.D. of four independent experiments
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which expression was downregulated 42-fold (Table 1).
Among the predicted targets, we focused on CDKN1A (also
known as p21), because it increases in response to oxidative
stress24 and has a major role in cell-cycle arrest.25 Real-time
PCR and western blot analysis showed that the transfection
of miR-302d mimic decreased CDKN1A (also p21
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Figure 2 miR-302d inhibits oxidant-induced cell death. hADSCs were transfected with miR-control or miR-302d for 48 h and were then treated with CoCl2 or SIN-1.
(a) Cells were treated with various concentrations of CoCl2 or SIN-1 for 20 h and cell viability was assessed with trypan blue exclusion method. The results were presented
as the percentage of total cells. (b) Flow-cytometric analysis of apoptotic cells. Cells were treated with 100mM CoCl2 or 5mM SIN-1 for 24 h and the fraction of apoptotic cells
displaying a subG1 DNA content was analyzed by FACS with PI. Cells with a sub-diploid DNA content (subG1) were considered to be apoptotic. (c) Analysis of apoptotic cells
with Annexin V staining. Cells were treated with the indicated oxidant for 16 h. The fraction of apoptotic cells was analyzed by flow cytometry after the cells were stained with
both Annexin V-FITC and PI. (d) Measurement of intracellular ROS generation using H2-DCFDA staining. The negative control is unstained cells. ROS level is presented as
the percentage of fluorescence intensity of the stained, control cells (right panel). *Po0.05, **Po0.01 versus CoCl2 or SIN-1 treated miR-control. $Po0.05 versus untreated
control. Data are shown as the mean±S.D. of three independent experiments
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Figure 3 The protective effect of miR-302d on oxidant-induced cell death is not associated with the Keap1/Nrf2 pathway. (a) The expression of Nrf2 and Keap1
mRNA in miR-302d-transfected hADSCs was assessed by real-time PCR. (b) Western blot analysis was performed with the indicated antibodies. Protein was isolated from
miR-302d-transfected hADSCs following CoCl2 exposure for 20 h. The protein expressions were quantified and shown as the ratio of untreated miR-control (right panel).
(c) Downregulation of Nrf2 expression by transfection of siR-Nrf2 was confirmed by real-time PCR. (d) Effect of Nrf2 siRNA on CoCl2-induced cell death. siR-control or siR-Nrf2
was transfected into miR-302d-transfected hADSCs. Following treatment with CoCl2, cell viability was assessed. **Po0.01 versus CoCl2 treated miR-control. ##Po0.01
versus siR-control. $Po0.05 versus untreated control. Data are shown as the mean±S.D. of three independent experiments
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expression) expression, and that the transfection of miR-
302d inhibitor increased CDKN1A (also p21 expression)
expression (Figures 4a and c–e). To determine the role of
CDKN1A in the action of miR-302d, we examined the effect
of CDKN1A siRNA on proliferation and cell death. The
transfection of CDKN1A siRNA decreased its expression
significantly at mRNA and protein levels (Figures 4b, d, and e),
increased the proliferation of hADSCs (Figure 4f), and
mitigated the modulation of hADSCs proliferation by miR-
302d inhibitor (Figure 4g). We also determined the effect of
miR-302d on the expression of cell cycle-related genes. The
transfection of miR-302d increased the expression of CDK2,
CDK6, cyclin A2, cyclin B1, cyclin B2 and cyclin D3 without
affecting the expression of cyclin D1 and cyclin E1
(Supplementary Figure 5). In contrast, the transfection of
CDKN1A siRNA did not affect CoCl2- and SIN-1-induced cell
death in hADSCs (Figure 4h). We determined the effect of
miR-302d on CDKN1A expression in the absence or
presence of CoCl2 and SIN-1. The treatment of CoCl2 and
SIN-1 increased CDKN1A expression in control miRNA or
miR-302d-transfected cells (Figure 4i). To determine whether
miR-302d directly binds to 3’UTR of CDKN1A, we used
luciferase reporter vector that contains a putative miR-302d
binding sequence of CDKN1A 3’UTR. Cells were transfected
with a luciferase construct in which the miR-302 target site
from the CDKN1A 3’UTR was inserted exhibited significantly
lower luciferase activity in miR-302 mimic-transfected
hADSCs than in control miRNA-transfected cells
(Figure 4j), indicating that miR-302d directly targets 3’UTR
of CDKN1A.
miR-302d-mediated repression of CCL5 reduces
oxidant-induced cell death in hADSCs. CCL5, which
was one of important target of miR-302s-induced regulation
of human fibroblasts proliferation,10 has been reported to be
activated by xanthine oxidase-mediated ROS production in
murine mesangial cells26 and to produce hydrogen peroxide
in human eosinophils.27 Real-time PCR analysis and
enzyme-linked immunosorbent analysis (ELISA) showed that
transfection of miR-302d mimic suppressed CCL5 mRNA
levels and protein levels in hADSCs (Figures 5a and b).
Then, we determined the effect of the downregulation of
CCL5 expression. The transfection of CCL5 siRNA in
hADSCs inhibited CCL5 mRNA and protein levels (Figures
5c and d). Downregulation of CCL5 expression did not affect
basal and miR-302-induced increase in hADSCs proliferation
(Figure 5e). We next tested whether the protective
effects of miR-302 against oxidant injury were mediated by
the suppression of CCL5 expression. Cell viability assay
revealed that downregulation of CCL5 via siR-CCL5
decreased CoCl2- and SIN-1-induced cell death like transfec-
tion of miR-302d, and cotransfection of miR-302d and CCL5
siRNA further increased cell viability (Figure 5f). Using real-
time PCR analysis (Figure 5g) and ELISA (Figure 5h), we
confirmed that CoCl2 and SIN-1 treatment upregulated CCL5
expression in hADSCs, and that transfection of miR-302d
reduced oxidant-induced increase in CCL5 expression
and the CCL5 siRNA and miR-302d-cotransfected cells
showed lower CCL5 protein level than that of miR-302d-
transfected cells. Transfection with siR-CCL5 also decreased
CoCl2- and SIN-1-induced ROS generation (Figure 5j).
To confirm the role of CCL5 in miR-302d-induced protection
of cell death, we determined the effect of recombinant CCL5
(Figure 5i). The addition of recombinant CCL5 (5mg/ml)
increased CoCl2-induced cell death and inhibited miR-302-
induced protection of CoCl2-induced cell death in hADSCs.
Bioinformatic analysis showed that 3’UTR of CCL5 mRNA
contains a putative target site for miR-302d, as described by
Kumar et al.10 To determine whether miR-302d directly binds
to 3’UTR of CCL5, we used luciferase reporter vector that
contains a putative miR-302d binding sequence of CCL5
3’UTR. Cells were transfected with a luciferase construct in
Table 1 Gene expression profile of miR-302d-overexpressing hADSCs.
Gene symbol Gene name Fold change
CYBRD1 Cytochrome b reductase 1 18.41
TGFBR2 Transforming growth factor, beta receptor II (70/80 kDa)  8.66
FOXQ1 Forkhead box Q1  5.32
RPS6KA2 Ribosomal protein S6 kinase, 90 kDa, polypeptide 2  3.32
ZNF25 Zinc finger protein 25  3.17
SDC1 Syndecan 1  3.03
TMOD2 Tropomodulin 2 (neuronal)  3.02
LOXL3 Lysyl oxidase-like 3  2.91
CDC2L6 Cell division cycle 2-like 6 (CDK8-like)  2.89
GPSM2 G-protein signaling modulator 2 (AGS3-like, C. elegans)  2.87
VLDLR Very low density lipoprotein receptor  2.72
TNFRSF10B Tumor necrosis factor receptor superfamily, member 10b  2.71
PON2 Paraoxonase 2  2.68
SCD5 Stearoyl-CoA desaturase 5  2.38
OXR1 Oxidation resistance 1  2.38
CYB5R4 Cytochrome b5 reductase 4  2.27
SYDE1 Synapse defective 1, Rho GTPase, homolog 1 (C. elegans)  2.25
MAFB v-maf musculoaponeurotic fibrosarcoma oncogene homolog B (avian)  2.22
CDKN1A Cyclin-dependent kinase inhibitor 1A (p21, Cip1)  2.21
SLFN11 Schlafen family member 11  2.19
COX7A1 Cytochrome c oxidase subunit VIIa polypeptide 1 (muscle)  2.15
HMOX1 Heme oxygenase (decycling) 1  2.12
PLOD2 Procollagen-lysine, 2-oxoglutarate 5-dioxygenase 2  2.09
Transfection of miR-302d significantly downregulated 23 cell-cycle and oxidative stress-related genes compared with miR-control-transfected cells
miR-302 protects oxidant-induced cell death
JY Kim et al
6
Cell Death and Disease
Days
6420
N
um
be
r o
f c
el
ls
0
20000
40000
60000
80000
100000
120000
140000
160000 miR-control + siR-control 
miR-control + siR-CDKN1A 
miR-302d + siR-control 
miR-302d + siR-CDKN1A 
##*
#**
*
+
–
–
+
siR-control
siR-CDKN1A
p21 (21 kDa) 
GAPDH (36 kDa) 
+
–
–
+
–
+
+
–
+ –
– +
miR-control
miR-302d
CDKN1A
miR
-
co
ntro
l
miR
-
302
dR
el
at
iv
e 
m
RN
A 
ex
pr
es
si
on
 
(F
old
 ch
an
ge
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
*
CDKN1A
siR
-
co
ntro
l
siR
-
CDK
N1A
R
el
at
iv
e 
m
RN
A 
ex
pr
es
si
on
 
(F
old
 ch
an
ge
)
0.0
0.2
0.4
0.6
0.8
1.0
1.2
##
Days
6420
N
um
be
r o
f c
el
ls
0
20000
40000
60000
80000
100000
120000
140000
160000 miR-control IH + siR-control 
miR-control IH + siR-CDKN1A 
miR-302d IH + siR-control 
miR-302d IH + siR-CDKN1A 
+
–
–
+
siR-control
siR-CDKN1A
p21 (21 kDa) 
GAPDH (36 kDa) 
+
–
–
+
–
+
+
–
+ –
– +
miR-control IH
miR-302d IH
#**
##**
#*
CDKN1A
miR
-co
ntro
l IH
miR
-
302
d IH
R
el
at
iv
e 
m
RN
A 
ex
pr
es
si
on
 
(F
old
 ch
an
ge
)
0.0
0.5
1.0
1.5
2.0
2.5
3.0 **
&
&& &
&
SIN-1 (mM)
0 5 10
Ce
ll 
vi
ab
ili
ty
 (%
)
0
20
40
60
80
100
120 miR-control + siR-control 
miR-control + siR-CDKN1A
miR-302d + siR-control 
miR-302d + siR-CDKN1A 
CoCl2 (μM)
0 100 200
Ce
ll 
vi
ab
ili
ty
 (%
)
0
20
40
60
80
100
120 miR-control + siR-control 
miR-control + siR-CDKN1A
miR-302d + siR-control 
miR-302d + siR-CDKN1A 
**
** **
*
$
$
$$
*
*
$
$
$ $
CDKN1A
CoCl 2(μM)
0 100R
el
at
iv
e 
m
RN
A 
ex
pr
es
si
on
 
(F
old
 ch
an
ge
)
0
5
10
15
20
25
miR-control 
miR-302d 
CDKN1A
SIN-1 (mM)
0 5R
el
at
iv
e 
m
RN
A 
ex
pr
es
si
on
 
(F
old
 ch
an
ge
)
0
5
10
15
20
miR-control 
miR-302d 
Luciferase activity/β-gal
(Fold change) 
0.0 0.2 0.4 0.6 0.8 1.0 1.2
pMIR-CDKN1A mut
pMIR-CDKN1A
miR-302d miR-control 
*
*
*
** **
$ $
*
Figure 4 The expression level of CDKN1A is involved in miR-302d-induced proliferation in hADSCs. (a and b) Downregulation of CDKN1AmRNA expression. Forty-eight
hours after transfection with indicated miRNA (a) or siRNA (b), cells were harvested for measurement of mRNA levels by real-time PCR. *Po0.05 versus miR-control.
##Po0.01 versus siR-control. (c) The increased expression of CDKN1A in miR-302d inhibitor (IH)-transfected hADSCs. **Po0.01 versus miR-control IH. (d and e)
Downregulation or upregulation of p21 (a protein that in humans is encoded by the CDKN1A gene) expression. Cells were transfected with indicated miRNA after transfection
with siR-control or siR-CDKN1A. Forty-eight hours after cotransfection of miRNA and siRNA, the protein levels of p21 were analyzed by western blotting. (f and g) Effect of
CDKN1A siRNA on proliferation. hADSCs with or without silencing of CDKN1A expression were transfected with miR-control or miR-302d (f), and with miR-control IH or
miR-302d IH (g). Cells were counted at different time points. *Po0.05, **Po0.01 versus miR-control (or miR-control IH). #Po0.05, ##Po0.01 versus siR-control. &Po0.05
versus miR-302d (or miR-302dIH)-transfected siR-control. (h) Effect of CDKN1A siRNA on oxidant-induced hADSCs death. Cells were transfected with siR-CDKN1A and/or
miR-302d and were then treated with CoCl2 or SIN-1. Cell viability was determined by trypan blue exclusion. (i) The CDKN1A mRNA level in oxidant-treated hADSCs after
transfection of miR-302d. The CDKN1A mRNA level was confirmed by real-time PCR at 48 h after transfection. *Po0.05, **Po0.01 versus CoCl2 or SIN-1 treated
miR-control. $Po0.05 versus untreated control. (j) Schematic diagram of luciferase reporter vector. The CDKN1A 3’UTR sequences containing the predicted miR-302d
binding site or mutated binding site (mut) were inserted into the pMIR-REPORT vector. The box shows the sequence alignment of miR-302d and its predicted binding site in
3’UTR of CDKN1A. miR-control or miR-302d was cotransfected with pMIR-CDKN1A or pMIR-CDKN1A mut luciferase constructs into hADSCs, respectively. Relative
luciferase activities were analyzed at 72 h post transfection. **Po0.01 versus miR-control. Data are represented the mean±S.D. of four independent experiments
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which the miR-302 target site from the CCL5 3’UTR was
inserted exhibited similar luciferase activity in miR-302 mimic-
transfected hADSCs with that in control miRNA-transfected
cells (Supplementary Figure 6).
Discussion
miR-302s are highly expressed in ESCs and have an
important role in the self-renewal and pluripotency of ESCs.
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However, the effect of miR-302 on cell proliferation is variable
depending on the cell type. miR-302 suppressed cell
proliferation in various cancer cells28–30 and tumorigenicity
of human ES cells,15 whereas the overexpression of miR-302
increased the fraction of S-phase cells in an NHF cell line.10
Cell counting and cell-cycle analysis in this study showed that
the transfection of miR-302 mimic increased the proliferation
of hADSCs and the fraction of S phase, but decreased Go/G1
phase (Figure 1). A similar change by miR-302a in cell-cycle
analysis showed in NHFs,31 although they have not deter-
mined whether overexpression of miR-302a increased the
proliferation of NHFs. We also observed an increase in
expression of cyclin A, cyclin B, CDK2 and CDK6 mRNA
(Supplementary Figure 5). In contrast, miR-302 has been
reported to have multiple cell-cycle targets in ESCs, including
the stem cell-related genesOct4/Sox2 and NR2F2, cyclin D1,
CDK2 andCDKN1A.8,13,15 This discrepancy can be explained
by the findings that miRNAs act independently in different cell
types, perhaps through the repression of different target
genes.20 The final biological effects of miRNAs strongly
depend on the repertoire of miRNAs, mRNA targets, and their
expression level, and the same miRNA may have opposite
roles in different cellular context.32 Chen et al.33 reported that
mir-181 showed the differential effects on differentiation of
B cells (CD19þ ) and cytotoxic T cells (CD8þ ), which are not
developmentally linked during hematopoietic lineage commit-
ment. The pro-senescence role of miR-20a34 and miR-29035
in mouse embryonic fibroblasts is in contrast with their
proliferative role in tumor and ESCs.36,37 All of these findings
indicated that miR-302s increase proliferation of hADSCs.
miR-302 has been reported to have multiple cell-cycle targets
in ESCs, including the stem cell-related genesOct4/Sox2 and
NR2F2, cyclin D1, CDK2 and CDKN1A.8,13,15 In this study,
microarray analysis showed that miR-302d inhibitedCDKN1A
expression (Table 1), and this result was confirmed by real-
time PCR and western blotting (Figures 4a and d). The p21
(CIP1/WAF1) protein binds to and inhibits the activity of cyclin-
CDK2, -CDK1, and -CDK4/6 complexes and thus functions as
a regulator of cell-cycle progression during G1 phase.38 A role
for CDKN1A in the miR-302-induced increase in cell
proliferation was supported by the findings that the down-
regulation of CDKN1A expression increased the proliferation
of hADSCs and blocked the action of miR-302d mimic and
inhibitor in hADSCs proliferation (Figures 4f and g). Our study
using luciferase construct showed that miR-302 directly binds
to 3’UTR of CDKN1A mRNA (Figure 4j). It has been shown
that miR-302 binds directly to the 3’-UTR of CDKN1A mRNA
in mouse ES cells39 and human ES cells.40 These data
indicated that miR-302-induced proliferation in hADSCs is
mediated by the targeting of CDKN1A mRNA. Kumar et al.10
reported that CCL5 has an important role in miR302-induced
fibroblast proliferation. Although we also observed that
miR-302d inhibited CCL5 expression, we did not observe an
increase in hADSCs proliferation following transfection of CCL5
siRNA (Figure 5e). The role of CCL5 in cell proliferation is
variable and depends on cell types. CCL5 increased cell
proliferation inMCF-7 cells41 but inhibited proliferation in human
fibroblasts.10 Thus, the discrepancy of the results may be
related to the cell types that were used in these experiments.
The most important finding of this study is that miR-302
protects hADSCs from CoCl2- and SIN-1-induced cell death.
Flow-cytometric analysis showed that miR-302d inhibited
apoptotic cell death that was induced by CoCl2 and SIN-
1(Figures 2b and c). CoCl2, which is a chemical hypoxia
agent, generates ROS.42,43 SIN-1 simultaneously produces
peroxide radicals and NO, which results in the production of
peroxynitrite.44 ROS determination using fluorescent dyes
showed that miR-302 transfection inhibited SIN-1- and CoCl2-
induced ROS generation and basal ROS levels (Figure 2d),
indicating that the miR-302d action is related to diminution of
ROS generation. In this study, the CoCl2- and SIN-1-induced
hADSCs death was not inhibited by transfection of CDKN1A
siRNA (Figure 4h), although the treatment of CoCl2 or SIN-1
increased CDKN1A expression (Figure 4i). The role of
CDKN1A on cell death is variable according to experimental
conditions. It has been reported that CDKN1A involved
in 5-aza-2-deoxycytidine-induced cell death in human
prostate cancer cells,45 epigallocatechin-3-gallate-induced
apoptosis46 and C(2)-ceraminde-induced apoptosis in mouse
embryonic fibroblasts.47 In contrast, CDKN1A inhibited
hyperoxia-induced cell death in H1299 human lung adeno-
carcinoma cells,48 apoptosis during DNA replication fork
stress,49 and shikonin-induced apoptosis.50 The negative
effect of CDKN1A siRNA on oxidant-induced cell death in this
experiment may also be related to incomplete knockdown
of CDKN1A expression. To exclude the role of CDKN1A on
miR-302d-mediated protection of hADSCs, we have to use
complete knockdown cells of CDKN1A gene.
Figure 5 miR-302d protects hADSCs from oxidant-induced cell death through a reduction in CCL5 expression. (a and c) Downregulation of CCL5 mRNA expression by
transfection of miR-302d or siR-CCL5. Forty-eight hours after transfection with miR-302d (a) or siR-CCL5 (c), cells were harvested for measurement of CCL5 mRNA levels.
Real-time PCR was performed to determine the CCL5 mRNA levels. (b and d) Downregulation of CCL5 protein expression by transfection of miR-302d or siR-CCL5. Cells
were transfected with miR-302d (b) or siR-CCL5 (d) for 48 h. After another 24 h in serum-free growth medium, cell-culture supernatant was harvested to measure the amounts
of CCL5 using the ELISA kit. (e) Effect of CCL5 siRNA on hADSCs proliferation. hADSCs with or without silencing of CCL5 expression were transfected with miR-control or
miR-302d. Cells were counted at different time points. *Po0.05, **Po0.01 versus miR-control. ##Po0.01 versus siR-control. (f) Effect of CCL5 siRNA on oxidant-induced
hADSCs death. Cells were transfected with siR-CCL5 and/or miR-302d and were then treated with CoCl2 or SIN-1. Cell viability was determined by trypan blue exclusion.
*Po0.05, **Po0.01 versus CoCl2 or SIN-1 treated miR-control. #Po0.05, ##Po0.01 versus CoCl2 or SIN-1 treated siR-control. $Po0.01 versus untreated control.
&Po0.05 versus miR-302d-transfected siR-control. (g) The CCL5 mRNA levels in oxidant-treated hADSCs after transfection of miR-302d were confirmed by real-time PCR.
(h) The CCL5 protein levels in oxidant-treated hADSCs after transfection of miR-302d were confirmed by ELISA. *Po0.05, **Po0.01 versus miR-control. #Po0.05,
##Po0.01 versus siR-control. $Po0.01 versus untreated control. &Po0.05 versus miR-302d-transfected siR-control. (i) hADSCs were transfected with miR-302d or siR-
CCL5 for 48 h, and were then cotreated with recombinant CCL5 (5mg/ml) and CoCl2 for 20 h. Cell viability was determined by trypan blue exclusion. **Po0.01 versus CoCl2
treated miR-control. $Po0.01 versus CoCl2 untreated control. $
C
Po0.01 versus CoCl2 treated and CCL5 untreated control. (j) Effect of CCL5 siRNA on oxidant-induced ROS
generation. siR-control or siR-CCL5 was transfected into hADSCs for 48 h. Following treatment with CoCl2 or SIN-1 for 24 h, intracellular ROS levels were quantitated by
H2-DCFDA staining using FACS. The graph showed the percentage of fluorescence intensity compared with the stained control cells (right panel).
#Po0.05, ##Po0.01
versus CoCl2 or SIN-1 treated siR-control.
$Po0.01 versus untreated control. Data are represented the mean±S.D. of four independent experiments
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In this study, in addition to inhibiting CCL5 expression by
miR-302d mimic (Figures 5a and b), we observed that the
CoCl2-induced increase in CCL5 expression was inhibited by
miR302d (Figures 5g and h) and that CCL5 siRNA transfec-
tion resulted in a protection against CoCl2- and SIN-1-induced
cell death (Figure 5f). The transfection of CCL5 siRNA also
inhibited CoCl2- and SIN-1-induced ROS generation
(Figure 5j) and the addition of recombinant CCL5 inhibited
miR-302d-induced protection about oxidant-induced cell
death (Figure 5i). An ROS-induced increase in CCL5
expression was also reported in airway epithelial cells51 and
a human fibroblast cell line.10 A reduction in tissue injury by
CCL5 inhibition has been reported in myocardial reperfusion
injury.52 All of these findings indicate that the inhibition of
oxidant-induced cell death by miR-302d is mediated in part by
the inhibition of CCL5. The luciferase assay using a construct
which contains a putative miR-302d target site ofCCL5 3’UTR
failed to show direct binding of miR-302d to CCL5 3’UTR
(Supplementary Figure 6). However, Kumar et al.10 showed
that miR-302a overexpression inhibited luciferase activity in
the experiment using a construct to which 400 bp of 3’UTR of
CCL5 was cloned. Therefore, this discrepancy may be
resulted from the possibility that the construct to be used in
the experiment may contain another binding site for miR-302.
The regulation of intracellular ROS levels has a critical role
in maintaining stemness, the differentiation of stem cells, and
the pathogenesis of stem cell-related diseases.53,54 The low
level of ROS in stem cells is maintained by the high level of
expression of anti-oxidant genes, enhanced DNA double-
strand break repair and the expression of heat-shock proteins.
The findings of this study suggest that high levels of miR-302
in pluripotent stem cells may also contribute to anti-oxidant
defense in stem cells and that regulation of redox status by
miR-302 in stem cells may have important roles in the
regulation of stem cell self-renewal and fate.
In conclusion, miR-302 regulates proliferation and protects
against oxidant-induced cell death. These actions are
mediated by the target genes CDKN1A and CCL5. The
modulation of miR-302 may be a novel strategy to protect
against ischemic tissue injury and/or to enhance the survival
of transplanted stem cells.
Materials and Methods
Cell culture. All protocols involving human subjects were approved by the
Institutional Review Board of Pusan National University. Superfluous materials
were collected from four individuals undergoing elective abdominoplasty after
informed consent was given by each individual. The hADSCs were isolated
according to the methods described in previous studies.55 hADSCs were
maintained in low-glucose DMEM with 10% fetal bovine serum, 100mg/ml
streptomycin and 100 U/ml penicillin in 5% CO2 environment at 37 1C. hBMSCs
were maintained in a-MEM with 10% fetal bovine serum, 100mg/ml streptomycin
and 100 U/ml penicillin in 5% CO2 environment at 37 1C.
Reagents. CoCl2 and SIN-1 were purchased from Sigma-Aldrich (St. Louis,
MO, USA). Recombinant human CCL5 was purchased from R&D Systems
(Minneapolis, MN, USA).
miRNA, siRNA transfection. hADSCs were seeded with complete medium
without antibiotics. On the following day, miR-302 (Dharmacon, Thermo Scientific,
Epsom, UK) at a final concentration of 20 nM and/or siRNA (on-TARGET plus
SMART pool, Thermo Scientific, Epsom, UK) for NFE2L2 (Nrf2), CDKN1A and
CCL5 at a final concentration of 100 nM were transfected to hADSCs using
DharmaFECT 1 (Thermo Scientific, Rockford, IL, USA) reagent according to the
manufacturer’s protocol. miRNA negative control or non-targeting siRNA was
transfected as a negative control.
Proliferation and colony-forming unit assay. hADSCs were trans-
fected with each miRNA and/or siRNA. After 48 h incubation, cells were seeded in
6-well plates at a density of 1 104 cells/well. In all, 2, 4 and 6 days later, the cells
were trypsinized and stained with trypan blue (Sigma, St. Louis, MO, USA). The
number of cells was counted using the Countess Automated Cell Counter
(Invitrogen, Carlsbad, CA, USA). Sixty cells were seeded in 60-mm dishes to
perform the CFU assay. The colonies were stained with crystal violet (Sigma) and
counted 10 days after plating.
Induction of differentiation. Transfected hADSCs were seeded in 12-well
plates at a density of 3 104 cells/cm2. After 24 h incubation, adipogenic
differentiation was induced by replacing with the adipogenic medium (10% FBS,
1 mM dexamethasone, 0.5 mM 3-isobutyl-1-methylxanthine, and 200mM indo-
methacin in a-MEM) for 7 days and assessed by staining with the Oil Red O dye
as an indicator of intracellular lipid accumulation. To induce osteogenic
differentiation, cells were seeded in 12-well plates at a density of 4 104 cells/
cm2 and incubated for 24 h before replacing with the osteogenic medium (10%
FBS, 0.1mM dexamethasone, 10mM b-glycerophosphate, and 50mM ascorbic
acid in a-MEM). After 21 days, osteogenic differentiation was determined by
staining with the Alizarin Red S to visualize calcification deposits.
Cell viability analysis. hADSCs were transfected with miRNA or siRNA.
After 48 h incubation, cells were seeded in 12-well plates at a density of 8 104
cells/well. On the following day, confluent cells were treated with CoCl2 or
SIN-1 for 20 h, trypsinized and stained with trypan blue (Sigma). The number
of viable and dead cells was counted using the Countess Automated Cell
Counter.
Cell-cycle analysis. hADSCs were harvested and fixed with 70% ethanol.
After extensive washing with HBSS, the cells were suspended in HBSS containing
RNase A and PI (Sigma). The cells were incubated for 30min at 37 1C before
flow-cytometric analysis using a FACS Canto II instrument (BD, San Jose, CA,
USA) and the acquired data were analyzed using the FlowJo software (Tree Star,
Ashland, OR, USA).
Annexin V staining assays for apoptosis. For Annexin V staining
assays, cells were stained with Annexin V–FITC and PI, and evaluated
for apoptosis by flow cytometry according to the manufacturer’s protocol (BD).
The apoptotic cells were determined using a FACS Canto II instrument (BD).
Assay for intracellular ROS detection. Intracellular ROS production
was measured with H2-DCFDA (Molecular Probes, Eugene, OR, USA) staining as
described according to the manufacturer’s instructions. Briefly, cells were pre-
incubated with H2-DCFDA for 30 min in 5% CO2 environment at 37 1C. After pre-
incubation step, the cells were treated with CoCl2 or SIN-1 for 20 h, floating and
adherent cells were collected. Changes in fluorescence intensity of each sample
were measured by the FACS Canto II instrument and analyzed by flow-cytometric
analysis using the FlowJo software.
Real-time PCR. Total cellular RNA was extracted with TRIzol reagent
(Invitrogen), followed by a reverse transcription with cDNA synthesis kit (Promega,
Madison, WI, USA). Small RNA species-enriched RNA isolation was performed as
per manufacturer’s instructions (mirVana miRNA isolation kit; Ambion, Austin, TX,
USA). miRNA was reverse transcribed using the Ncode miRNA first-strand cDNA
synthesis kit (Invitrogen), according to the manufacturer’s specified guidelines.
Quantitative RT-PCR analysis was performed using SYBR Green PCR Master Mix
on ABI 7500 system (Applied Biosystems, Warrington, UK).
Western blot analysis. Samples were homogenized in RIPA buffer
(Sigma).The isolated proteins were separated by SDS-PAGE and electro-
transferred onto PVDF membranes (Millipore, Bedford, MA, USA). Blots were
probed with primary antibodies, followed by HRP-conjugated secondary
antibodies. Antibodies used in this study were purchased as indicated: Bad,
Bak, Bax, Bcl-2, Bcl-XL, Keap1 and p21 from Santa Cruz Biotechnology (Dallas,
TX, USA); Nrf-2 and p-Nrf-2 from Abcam (Cambridge, MA, USA); HO-1 from Enzo
life sciences(Farmingdale, NY, USA); GAPDH from Cell Signaling Technologies
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(Boston, MA, USA). Bound antibodies were detected using an ECL detection kit
(Pierce Biotechnology, Rockford, IL, USA) and visualized using LAS 3000
Luminoimage Analyzer (Fujifilm, Tokyo, Japan).
Microarray analysis. Total RNA was extracted with TRIzol (Invitrogen) and
purified using RNeasy columns (Qiagen, Hilden, Germany) according to the
manufacturer’s instructions. Microarray analysis was carried out by Macrogen Inc.
(Seoul, Korea). Briefly, biotinylated complementary RNAs were amplified and purified
using the Ambion Illumina RNA amplification kit (Ambion) according to the
manufacturer’s instructions. Labeled cRNA samples were hybridized to each human
HT-12 expression v.4 bead array according to the manufacturer’s instructions
(Illumina, SanDiego, CA, USA). Detection of array signal was carried out using
Amersham fluoroLink streptavidin-Cy3 (GE Healthcare Bio-Sciences, Uppsala,
Sweden). Arrays were scanned with an Illumina bead array Reader confocal
scanner, and the raw data were extracted using the software provided by the
manufacturer (Illumina GenomeStudio v2011.1 (Gene Expression Module v1.9.0)).
Reporter vectors and DNA constructs. A putative miR-302d-recogni-
tion element (as single copy) from the CDKN1A or CCL5 gene was cloned in the
3’- UTR of the firefly luciferase reporter vector according to the manufacturer’s
specified guidelines. The oligonucleotide sequences were designed to carry the
HindIII and SpeI sites at their extremities facilitating ligation into the HindIII and
SpeI sites of pMIR-Report (Ambion). The oligonucleotides used in these studies
were pMIR-CDKN1A FW, 50-CTAGTTTCTTTTTCATTTGAGAAGTAAACAGATGG
CACTTTGAAGGGGCCTCACCGA-30, RV, 50-AGCTTCGGTGAGGCCCCTTCAAA
GTGCCATCTGTTTACTTCTCAAATGAAAAAGAAA-30; pMIR-CDKN1A mut FW,
5’-CTAGTTTCTTTTTCATTTGAGAAGTCCCACGATGTACAGGTGAAGGGGCCT
CACCGA-3’, RV, 50-AGCTTCGGTGAGGCCCCTTCACCTGTACATCGTGGGACT
TCTCAAATGAAAAAGAAA-30; pMIR-CCL5 FW, 50-CTAGTGGCTGGACGTGGTG
GCTCACGCCTGTAATCCCAGCACTTTGGGAGGCCAAGA-30 RV, 50-AGCTTCT
TGGCCTCCCAAAGTGCTGGGATTACAGGCGTGAGCCACCACGTCCAGCCA-30
pMIR-CCL5 mut FW, 50-CTAGTGGCTGGACGTGGTGTAGACCGACGTTCATCC
CCTACAGGTGGGAGGCCAAGA-30 RV, 50-AGCTTCTTGGCCTCCCACCTGTAG
GGGATGAACGTCGGTCTACACCACGTCCAGCCA-30.
Reporter gene assay. Luciferase reporter assay was performed using
Luciferase Assay System (Promega) according to the manufacturer’s specified
guidelines. Briefly, DharmaFECT Duo Transfection Reagent (Thermo Scientific,
Epsom, UK) was used for cotransfection of reporter plasmid and miRNA mimic.
The pMIR-CDKN1A or pMIR-CCL5 and pMIR-b-gal plasmids were used as
reporter constructs. The cells were harvested 72 h after transfection, lysed in RLB
buffer, and subsequently assayed for their luciferase activity by Victor3 Multilabel
Plate Reader (Perkin-Elmer, Waltham, MA, USA). The transfections were
performed in duplicate, and all experiments were repeated several times. The
luciferase assays were normalized according to their b-galactosidase activity.
ELISA. The cell-culture supernatants from hADSCs were subjected to ELISA.
The secretion of CCL5 was measured with commercially available ELISA kits
(R&D Systems) according to the manufacturer’s instructions. The absorbance
(450 nm) for each sample was analyzed using Sunrise Microplate Reader (TECAN
SUNRISE, Ma¨nnedorf, Switzerland).
Statistical analysis. Data are presented as the mean±S.D. of independent
experiments with similar results. Statistical comparisons between experimental
groups were performed with ANOVA test or two-tailed Student’s t-test. Po0.05
was considered as statistically significant.
Conflict of Interest
The authors declare no conflict of interest.
Acknowledgements. This study was supported by the National Research
Foundation of Korea (NRF) grant founded by the Korea Government (MSIP;
2012M3A9B4028558) and the MRC program of MEST/KOSEF (2007-0052078).
1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116:
281–297.
2. Nelson P, Kiriakidou M, Sharma A, Maniataki E, Mourelatos Z. The microRNA world: small
is mighty. Trends Biochem Sci 2003; 28: 534–540.
3. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small
RNAs with antisense complementarity to lin-14. Cell 1993; 75: 843–854.
4. Johnston RJ, Hobert O. A microRNA controlling left/right neuronal asymmetry in
Caenorhabditis elegans. Nature 2003; 426: 845–849.
5. Esquela-Kerscher A, Slack FJ. Oncomirs - microRNAs with a role in cancer. Nat Rev
Cancer 2006; 6: 259–269.
6. Lin SL, Chang DC, Chang-Lin S, Lin CH, Wu DT, Chen DT et al. Mir-302 reprograms
human skin cancer cells into a pluripotent ES-cell-like state. RNA 2008; 14: 2115–2124.
7. Lin SL, Chang DC, Lin CH, Ying SY, Leu D, Wu DT. Regulation of somatic
cell reprogramming through inducible mir-302 expression. Nucleic Acids Res 2011; 39:
1054–1065.
8. Subramanyam D, Lamouille S, Judson RL, Liu JY, Bucay N, Derynck R et al. Multiple
targets of miR-302 and miR-372 promote reprogramming of human fibroblasts to induced
pluripotent stem cells. Nat Biotechnol 2011; 29: 443–448.
9. Miyoshi N, Ishii H, Nagano H, Haraguchi N, Dewi DL, Kano Y et al. Reprogramming of
mouse and human cells to pluripotency using mature microRNAs. Cell Stem Cell 2011; 8:
633–638.
10. Kumar MG, Patel NM, Nicholson AM, Kalen AL, Sarsour EH, Goswami PC. Reactive
oxygen species mediate microRNA-302 regulation of AT-rich interacting domain 4a and
C-C motif ligand 5 expression during transitions between quiescence and proliferation.
Free Radic Biol Med 2012; 53: 974–982.
11. Kang H, Louie J, Weisman A, Sheu-Gruttadauria J, Davis-Dusenbery BN, Lagna G et al.
Inhibition of microRNA-302 (miR-302) by bone morphogenetic protein 4 (BMP4) facilitates
the BMP signaling pathway. J Biol Chem 2012; 287: 38656–38664.
12. Lipchina I, Elkabetz Y, Hafner M, Sheridan R, Mihailovic A, Tuschl T et al. Genome-wide
identification of microRNA targets in human ES cells reveals a role for miR-302 in
modulating BMP response. Genes Dev 2011; 25: 2173–2186.
13. Lin SL, Chang DC, Ying SY, Leu D, Wu DT. MicroRNA miR-302 inhibits the tumorigenecity
of human pluripotent stem cells by coordinate suppression of the CDK2 and CDK4/6 cell
cycle pathways. Cancer Res 2010; 70: 9473–9482.
14. Barroso-delJesus A, Lucena-Aguilar G, Sanchez L, Ligero G, Gutierrez-Aranda I,
Menendez P. The Nodal inhibitor Lefty is negatively modulated by the microRNA miR-302
in human embryonic stem cells. FASEB J 2011; 25: 1497–1508.
15. Hu S, Wilson KD, Ghosh Z, Han L, Wang Y, Lan F et al. MicroRNA-302 increases
reprogramming efficiency via repression of NR2F2. Stem Cells 2013; 31: 259–268.
16. Zuk PA, Zhu M, Ashjian P, De Ugarte DA, Huang JI, Mizuno H et al. Human adipose tissue
is a source of multipotent stem cells. Mol Biol Cell 2002; 13: 4279–4295.
17. Rodriguez AM, Elabd C, Amri EZ, Ailhaud G, Dani C. The human adipose tissue is a source
of multipotent stem cells. Biochimie 2005; 87: 125–128.
18. Gimble JM, Guilak F. Differentiation potential of adipose derived adult stem (ADAS) cells.
Curr Top Dev Biol 2003; 58: 137–160.
19. Kim YJ, Bae SW, Yu SS, Bae YC, Jung JS. miR-196a regulates proliferation and
osteogenic differentiation in mesenchymal stem cells derived from human adipose tissue.
J Bone Miner Res 2009; 24: 816–825.
20. Kim YJ, Hwang SH, Cho HH, Shin KK, Bae YC, Jung JS. MicroRNA 21 regulates the
proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat
diet-induced obesity alters microRNA 21 expression in white adipose tissues. J Cell Physiol
2012; 227: 183–193.
21. Koopman G, Reutelingsperger CP, Kuijten GA, Keehnen RM, Pals ST, van Oers MH.
Annexin V for flow cytometric detection of phosphatidylserine expression on B cells
undergoing apoptosis. Blood 1994; 84: 1415–1420.
22. Kaspar JW, Niture SK, Jaiswal AK. Nrf2:INrf2 (Keap1) signaling in oxidative stress. Free
Radic Biol Med 2009; 47: 1304–1309.
23. Ryter SW, Choi AM. Heme oxygenase-1/carbon monoxide: from metabolism to molecular
therapy. Am J Respir Cell Mol Biol 2009; 41: 251–260.
24. Macip S, Igarashi M, Fang L, Chen A, Pan ZQ, Lee SW et al. Inhibition of p21-mediated
ROS accumulation can rescue p21-induced senescence. EMBO J 2002; 21: 2180–2188.
25. Besson A, Dowdy SF, Roberts JM. CDK inhibitors: cell cycle regulators and beyond. Dev
Cell 2008; 14: 159–169.
26. Satriano JA, Banas B, Luckow B, Nelson P, Schlondorff DO. Regulation of RANTES and
ICAM-1 expression in murine mesangial cells. J Am Soc Nephrol 1997; 8: 596–603.
27. Kapp A, Zeck-Kapp G, Czech W, Schopf E. The chemokine RANTES is more than a
chemoattractant: characterization of its effect on human eosinophil oxidative metabolism and
morphology in comparison with IL-5 and GM-CSF. J Invest Dermatol 1994; 102: 906–914.
28. Wang L, Yao J, Shi X, Hu L, Li Z, Song T et al.MicroRNA-302b suppresses cell proliferation
by targeting EGFR in human hepatocellular carcinoma SMMC-7721 cells. BMC Cancer
2013; 13: 2407–13-448.
29. Cai N, Wang YD, Zheng PS. The microRNA-302-367 cluster suppresses the proliferation of
cervical carcinoma cells through the novel target AKT1. RNA 2013; 19: 85–95.
30. Fareh M, Turchi L, Virolle V, Debruyne D, Almairac F, de-la-Forest Divonne S et al.
The miR 302-367 cluster drastically affects self-renewal and infiltration properties of
glioma-initiating cells through CXCR4 repression and consequent disruption of the
SHH-GLI-NANOG network. Cell Death Differ 2012; 19: 232–244.
31. Card DA, Hebbar PB, Li L, Trotter KW, Komatsu Y, Mishina Y et al.Oct4/Sox2-regulated miR-
302 targets cyclin D1 in human embryonic stem cells. Mol Cell Biol 2008; 28: 6426–6438.
miR-302 protects oxidant-induced cell death
JY Kim et al
12
Cell Death and Disease
32. Rizzo M, Mariani L, Pitto L, Rainaldi G, Simili M. miR-20a and miR-290, multi-faceted players
with a role in tumourigenesis and senescence. J Cell Mol Med 2010; 14: 2633–2640.
33. Chen CZ, Li L, Lodish HF, Bartel DP. MicroRNAs modulate hematopoietic lineage
differentiation. Science 2004; 303: 83–86.
34. Poliseno L, Pitto L, Simili M, Mariani L, Riccardi L, Ciucci A et al. The proto-oncogene LRF
is under post-transcriptional control of MiR-20a: implications for senescence. PLoS One
2008; 3: e2542.
35. Pitto L, Rizzo M, Simili M, Colligiani D, Evangelista M, Mercatanti A et al.miR-290 acts as a
physiological effector of senescence in mouse embryo fibroblasts. Physiol Genomics 2009;
39: 210–218.
36. He L, Thomson JM, Hemann MT, Hernando-Monge E, Mu D, Goodson S et al.
A microRNA polycistron as a potential human oncogene. Nature 2005; 435: 828–833.
37. Marson A, Levine SS, Cole MF, Frampton GM, Brambrink T, Johnstone S et al. Connecting
microRNA genes to the core transcriptional regulatory circuitry of embryonic stem cells.
Cell 2008; 134: 521–533.
38. Gartel AL, Radhakrishnan SK. Lost in transcription: p21 repression, mechanisms, and
consequences. Cancer Res 2005; 65: 3980–3985.
39. Chang HM, Martinez NJ, Thornton JE, Hagan JP, Nguyen KD, Gregory RI. Trim71
cooperates with microRNAs to repress Cdkn1a expression and promote embryonic stem
cell proliferation. Nat Commun 2012; 3: 923.
40. Dolezalova D, Mraz M, Barta T, Plevova K, Vinarsky V, Holubcova Z et al. MicroRNAs
regulate p21(Waf1/Cip1) protein expression and the DNA damage response in human
embryonic stem cells. Stem Cells 2012; 30: 1362–1372.
41. Murooka TT, Rahbar R, Fish EN. CCL5 promotes proliferation of MCF-7 cells throughmTOR-
dependent mRNA translation. Biochem Biophys Res Commun 2009; 387: 381–386.
42. Zou W, Yan M, Xu W, Huo H, Sun L, Zheng Z et al. Cobalt chloride induces PC12
cells apoptosis through reactive oxygen species and accompanied by AP-1 activation.
J Neurosci Res 2001; 64: 646–653.
43. Chachami G, Simos G, Hatziefthimiou A, Bonanou S, Molyvdas PA, Paraskeva E. Cobalt
induces hypoxia-inducible factor-1alpha expression in airway smooth muscle cells by a
reactive oxygen species- and PI3K-dependent mechanism. Am J Respir Cell Mol Biol
2004; 31: 544–551.
44. Darley-Usmar VM, Hogg N, O’Leary VJ, Wilson MT, Moncada S. The simultaneous
generation of superoxide and nitric oxide can initiate lipid peroxidation in human low density
lipoprotein. Free Radic Res Commun 1992; 17: 9–20.
45. Pulukuri SM, Rao JS. Activation of p53/p21Waf1/Cip1 pathway by 5-aza-2’-deoxycytidine
inhibits cell proliferation, induces pro-apoptotic genes and mitogen-activated protein
kinases in human prostate cancer cells. Int J Oncol 2005; 26: 863–871.
46. Hastak K, Agarwal MK, Mukhtar H, Agarwal ML. Ablation of either p21 or Bax prevents
p53-dependent apoptosis induced by green tea polyphenol epigallocatechin-3-gallate.
FASEB J 2005; 19: 789–791.
47. Fujiwara K, Daido S, Yamamoto A, Kobayashi R, Yokoyama T, Aoki H et al. Pivotal role of
the cyclin-dependent kinase inhibitor p21WAF1/CIP1 in apoptosis and autophagy. J Biol
Chem 2008; 283: 388–397.
48. Wu YC, O’Reilly MA. Bcl-X(L) is the primary mediator of p21 protection against
hyperoxia-induced cell death. Exp Lung Res 2011; 37: 82–91.
49. Rodriguez R, Meuth M. Chk1 and p21 cooperate to prevent apoptosis during DNA
replication fork stress. Mol Biol Cell 2006; 17: 402–412.
50. Ahn J, Won M, Choi JH, Kim YS, Jung CR, Im DS et al. Reactive oxygen species-mediated
activation of the Akt/ASK1/p38 signaling cascade and p21(Cip1) downregulation are
required for shikonin-induced apoptosis. Apoptosis 2013; 18: 870–881.
51. Casola A, Burger N, Liu T, Jamaluddin M, Brasier AR, Garofalo RP. Oxidant tone regulates
RANTES gene expression in airway epithelial cells infected with respiratory syncytial
virus. Role in viral-induced interferon regulatory factor activation. J Biol Chem 2001; 276:
19715–19722.
52. Braunersreuther V, Pellieux C, Pelli G, Burger F, Steffens S, Montessuit C et al.
Chemokine CCL5/RANTES inhibition reduces myocardial reperfusion injury in athero-
sclerotic mice. J Mol Cell Cardiol 2010; 48: 789–798.
53. Chaudhari P, Ye Z, Jang YY. Roles of reactive oxygen species in the fate of stem cells.
Antioxid Redox Signal 2012; 20: 1881–1890.
54. Crespo FL, Sobrado VR, Gomez L, Cervera AM, McCreath KJ. Mitochondrial reactive
oxygen species mediate cardiomyocyte formation from embryonic stem cells in high
glucose. Stem Cells 2010; 28: 1132–1142.
55. Kim Y, Kim H, Cho H, Bae Y, Suh K, Jung J. Direct comparison of human
mesenchymal stem cells derived from adipose tissues and bone marrow in mediating
neovascularization in response to vascular ischemia. Cell Physiol Biochem 2007; 20:
867–876.
Cell Death and Disease is an open-access journal
published by Nature Publishing Group. This work is
licensed under a Creative Commons Attribution-NonCommercial-
NoDerivs 3.0 Unported License. The images or other third party
material in this article are included in the article’s Creative Commons
license, unless indicated otherwise in the credit line; if the material is
not included under the Creative Commons license, users will need to
obtain permission from the license holder to reproduce thematerial. To
view a copy of this license, visit http://creativecommons.org/licenses/
by-nc-nd/3.0/
Supplementary Information accompanies this paper on Cell Death and Disease website (http://www.nature.com/cddis)
miR-302 protects oxidant-induced cell death
JY Kim et al
13
Cell Death and Disease
